Proven to significantly reduce excess abdominal fat.See the Results
It stimulates the body's own pulsatile release of growth hormone.Learn about the mechanism of action
*Also known as excess abdominal fat.
†A newly approved strength of tesamorelin for injection with the same efficacy and safety of tesamorelin 1 mg/vial. The 2 mg/vial is more concentrated than the 1 mg/vial, and the recommended daily dose is 1.4 mg.
Important Information Regarding EGRIFTA SV™ (tesamorelin for injection) and COVID-19 Pandemic.
The full Prescribing Information and Important Safety Information about EGRIFTA SV™ are available here.